Berlin, Germany:
Britain’s approval of BioNTech-Pfizer’s vaccine against Covid-19 marks a “historic moment” in the battle against the pandemic, the US pharma group’s chief executive stated Wednesday, following his enterprise won the very first such authorisation in the West.
“Today’s Emergency Use Authorisation in the UK marks a historic moment in the fight against Covid-19,” stated Pfizer CEO Albert Bourla.
The US enterprise and Germany’s BioNTech added that they anticipated additional regulatory choices from other nations “in the coming days and weeks”.
()